This 2009 NCDEU Poster Session was published in October 2009 and is eligible for AMA PRA Category 1 Credit™ through April 30, 2010. The latest review of this material was September 2009.
To obtain credit for this activity, study the material and complete the CME Posttest and Evaluation.
After completing this educational activity, you should be able to:
This special 2009 NCDEU Annual Meeting Poster Session was developed for CME credit designation on the basis of our assessment of the needs of Web site visitors, with the purpose of providing visitors with a curriculum of posters on a variety of topics.
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The CME Institute of Physicians Postgraduate Press, Inc., designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The presenters for this CME activity and the CME Institute staff were asked to complete a statement regarding all relevant personal financial relationships between themselves and their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. No member of the CME Institute staff reported any relevant personal financial relationships. Financial disclosures from the presenters are as follows:
Ms Bun is an employee of NeuroComp Systems, Inc.
Dr Canuso is an employee of Ortho-McNeil Janssen Scientific Affairs, LLC, and is a stock shareholder of Johnson & Johnson.
Dr Carothers is an employee of Ortho-McNeil Janssen Scientific Affairs, LLC, and is a stock shareholder of Johnson & Johnson.
Ms Goldberg is an employee of NeuroComp Systems, Inc.
Ms Gooch is an employee of NeuroComp Systems, Inc.
Mr Gripeos is a consultant for NeuroComp Systems, Inc.
Dr Kalali is an employee of Quintiles, Inc; is a consultant for AstraZeneca, Janssen, and Vanda; is a member of the speakers/advisory boards for AstraZeneca and GlaxoSmithKline; and is on the board of directors of Cypress Biosciences.
Mr Kemp is an employee of NeuroComp Systems, Inc.
Ms Kosik-Gonzalez is an employee of Ortho-McNeil Janssen Scientific Affairs, LLC.
Dr Lindenmayer is a consultant for Janssen and Eli Lilly and has received grant/research support from Janssen, AstraZeneca, Organon, Bristol-Myers Squibb, Azur, Dainippon Sumimoto, and Otsuka.
Dr O’Halloran is a stock shareholder of NeuroComp Systems, Inc.
Dr Reist has received grant/research support from Bristol-Myers Squibb and is a member of the speakers/advisory boards for AstraZeneca and Jazz.
Dr Schooler has received grant/research support from Bristol-Myers Squibb, Eli Lilly, Ortho-McNeil Janssen, Pfizer, and AstraZeneca and is a member of the speakers/advisory boards for Eli Lilly, Ortho-McNeil Janssen, Schering-Plough, Lundbeck, and Organon.
Dr Stroup is a consultant for Eli Lilly and Janssen.
Mr Turkoz is an employee of Ortho-McNeil Janssen Scientific Affairs, LLC, and is a stock shareholder of Johnson & Johnson.
Drs Bondi, Covell, Essock, Lencz, Malhotra, McEvoy, Palmer, and Zhang have no personal financial relationships to disclose relative to this presentation.
In this 2009 NCDEU Poster Session, participants may be presenting investigational information about pharmaceutical agents that is outside US Food and Administration–labeling. This information is intended solely as continuing medical education and is not intended to promote off-label use of any of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
This 2009 NCDEU Poster Session has been reviewed for accuracy and fair balance by a selection committee of the American Society of Clinical Psychopharmacology (ASCP), and a member of the External CME Advisory Board has reviewed this poster session to determine whether the material is evidence-based and objective.
This 2009 NCDEU Poster Session is derived from the 49th Annual NCDEU Meeting, which was held June 29–July 2, 2009, in Hollywood, Florida, and was independently developed by the CME Institute of Physicians Postgraduate Press, Inc., the National Institute of Mental Health (NIMH), and the ASCP. The opinions expressed herein are those of the presenters and do not necessarily reflect the opinions of the CME provider and publisher, the NIMH, or the ASCP.
